Arindam Sarkar

Arindam Sarkar

Auto-generated profile, based on publicly available information

Arindam Sarkar

Department of Pharmaceutical Technology, Jadavpur University

Research Focus & Metrics

Academic Career Length

2Years (2025-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
12 September 2025 in Journal of Biomaterials Science, Polymer Edition
Verified
Journal Article
Closed access
DRDhiman Roy
Dhiman Roy
ASArindam Sarkar
Arindam Sarkar
ABAdarsha Bachhar
Adarsha Bachhar
UDUSHASI DAS
USHASI DAS
Sanchita MandalSanchita Mandal
Sanchita Mandal
Natural exudates like Gum Odina, a complex polysaccharide, released by plants upon injury, is in high demand for applications such as food additives, emulsifiers, and binders owing to its safety, non-toxicity, and commercial viability, particularly within the pharmaceutical industry. This gum, composed of D-galactose, L-arabinose, aldobiouronic acid, and D-galacturonic acid, exhibits medicinal properties and has been explored for drug administration methods. Rheological studies revealed that Gum Odina dispersions possessed pseudoplastic characteristics, with viscosity increasing with concentration but decreasing with elevated temperature and salinity. Comprehensive analyses, including FTIR, XRD, AFM, TGA, DSC, Raman, CD spectroscopy, and NMR, were conducted to understand its properties. Furthermore, Gum Odina has demonstrated in vitro antioxidant activities against hydroxyl and superoxide radicals, indicating a significant antioxidant capacity. The inherent modifiability of Gum Odina, through chemical or biochemical means such as cross-linking, grafting, fabrication of spongy scaffolds, and coacervates, alters the gum's polysaccharide structure to enhance specific performance characteristics such as solubility, viscosity, swelling capacity, and gelation behavior, enabling customization for commercial and therapeutic applications. This review article explores Gum Odina's novel modification strategies, comprehensive physicochemical characterization, and diverse multifunctional applications, particularly in pharmaceutical preparations. The review highlights Gum Odina's tailored properties and compares its structural, functional, and rheological attributes to conventional plant gums like acacia gum. This review also addresses the economic importance, safety, biodegradability, and biocompatibility of Gum Odina, positioning it as a suitable natural, eco-friendly excipient. Its unique arabinogalactan polymer structure offers advantages over traditional gums in biopolymer application.

5 March 2026 in Journal of Biomaterials Science, Polymer Edition
Verified
Journal Article
Closed access
ABAdarsha Bachhar
Adarsha Bachhar
SBShila Barman
Shila Barman
ASArindam Sarkar
Arindam Sarkar
ABAryama Bose
Aryama Bose
PBPoulomi Biswas
Poulomi Biswas
SMSanchita Mandal
Sanchita Mandal
The efficient gastric absorption of orally administered drugs showing pH-dependent solubility, narrow absorption windows, or localized gastric action remains a critical challenge. Conventional immediate-release and sustained-release dosage forms often result in poor bioavailability, fluctuating plasma drug levels, and increased dosing frequency due to rapid gastric emptying and variable gastrointestinal transit. Presently, expandable, high-density, and mucoadhesive systems represent the most widely investigated gastroretentive approaches; unfortunately, these systems have exhibited limited clinical outcomes because of formulation complexity and unacceptably variable gastric retention. FRDDS represents a promising clinically relevant strategy that overcomes such limitations via the formation of low-density buoyant gel structures that can reside in the stomach for prolonged periods. Maintenance of the drug in the gastric milieu by FRDDS enhances dissolution under acidic conditions, allowing for controlled and site-specific drug release and improving therapeutic efficacy while reducing dosing frequency. This review provides a critical evaluation of recent advances in FRDDS, focusing on mechanisms of raft formation, gastroretentive performance, formulation strategies, and their clinical applicability. Inter-individual variability in the gastric environment, fed-fasted effects, and translational limitations are discussed as key challenges. Overall, FRDDS embodies a robust and versatile gastroretentive platform with significant potential to improve oral drug therapy in chronic, infectious, and gastric-related diseases.